Biogen stock price target raised to $251 by H.C. Wainwright
Covered in this story
What has happened since
- Biogen is up 19.8% since this was published, 81 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
H.C. Wainwright’s $251 target on $BIIB is on the record and being tracked to Jul 2027 (12-month default), scored on the close that day.
H.C. Wainwright’s track record →Analyst targets on Biogen
- BMO Capital Markets: $229 → $220 by Oct 2027 · Market Perform via Investing.com
- Wolfe Research: $216 → $300 by Sep 2027 · Outperform via Yahoo Finance
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $BIIB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Biogen →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.